| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.51 | 0.06 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |